EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ultrasound‐Responsive Dual‐Prodrug Nanoassembly for “Fenestrae‐Restoration Strategy” in Liver Fibrosis Therapy

Shutong Liu, Mengyao Zhang, Zitong Qiu, Xinyi Liu, Yunsheng Dou, Sona Krizkova, Zheyi Li, Zbynek Heger iD, Nan Li

Advanced Materials · 2026-04 · 38 (22)

DOI: 10.1002/adma.202518832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 20.03.2026. Verfasst von Shutong Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, …. Hauptthemen laut MEDLINE: Liver Cirrhosis, Prodrugs, Ultrasonic Waves. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Natural Science Foundation, Tianjin Youth Science and Technology Talent Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis is a serious yet reversible intermediate stage in the progression of liver disease, which can ultimately advance to cirrhosis and hepatocellular carcinoma. Targeted and selective inhibition of activated hepatic stellate cells (aHSCs) has emerged as a promising therapeutic strategy for the treatment of liver fibrosis. However, the capillarization of liver sinusoidal endothelial cells (LSECs) characterized by the loss of fenestrae and continuous formation of basement membrane presents a significant barrier to effective delivery of anti‐fibrotic agents. In this study, we propose a novel “fenestrae‐restoration strategy” employing ultrasound‐responsive polymeric dual prodrug nanoassembly (PMS) co‐loaded with nitric oxide prodrug (mSNO) and poly‐metformin (PMet). PMS is engineered for controllable, ultrasound‐triggered release of nitric oxide from mSNO, which activates soluble guanylate cyclase. This results in upregulation of intracellular cyclic guanosine monophosphate that facilitates the reversal of LSECs capillarization, restoring fenestrae and enhancing endothelial permeability. This restoration enables PMS to traverse the hepatic sinusoidal barrier, followed by accumulation in fibrotic tissue, where PMet is internalized by aHSCs. In lysosomes, metformin released from PMet ultimately inhibits aHSCs proliferation and migration via the AMPK‐mTOR pathway deregulation. The therapeutic efficacy and underlying mechanisms of “fenestrae‐restoring strategy” were comprehensively validated in preclinical CCl 4 ‐induced murine model of liver fibrosis. These findings provide interesting insights into the combination therapy of liver fibrosis and paves new avenues for future development of smart therapeutic modalities utilizing stimuli‐responsive biosafe nanotherapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisProdrugsUltrasonic WavesAnimalsMetforminNitric OxideMiceHepatic Stellate CellsHumansCell ProliferationPolymersCell MovementMaleEndothelial Cells

Stichwörter der Autor:innen

fenestrae restorationliver fibrosisliver sinusoidal endothelial cellsmetforminnitric oxide

Substanzen

MetforminNitric OxideProdrugsPolymers

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin, P. R. China.
  • Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic.
  • Center of Advanced Innovation Technologies, Faculty of Materials Science and Technology, VSB - Technical University of Ostrava, Ostrava, Czech Republic.

ORCID-Profile: Zbynek Heger

Förderung

  • National Natural Science Foundation of China
  • Tianjin Natural Science Foundation
  • Tianjin Youth Science and Technology Talent Program
  • Natural Science Foundation of Tianjin Municipality

Zitieren

APA

Liu, S., Zhang, M., Qiu, Z., Liu, X., Dou, Y., Krizkova, S., Li, Z., Heger, Z., & Li, N. (2026). Ultrasound‐Responsive Dual‐Prodrug Nanoassembly for “Fenestrae‐Restoration Strategy” in Liver Fibrosis Therapy. Advanced Materials, 38(22). https://doi.org/10.1002/adma.202518832

Vancouver

Liu S, Zhang M, Qiu Z, Liu X, Dou Y, Krizkova S, et al. Ultrasound‐Responsive Dual‐Prodrug Nanoassembly for “Fenestrae‐Restoration Strategy” in Liver Fibrosis Therapy. Advanced Materials. 2026;38(22). doi:10.1002/adma.202518832

BibTeX
@article{Liu2026,
  author = {Liu, Shutong and Zhang, Mengyao and Qiu, Zitong and Liu, Xinyi and Dou, Yunsheng and Krizkova, Sona and Li, Zheyi and Heger, Zbynek and Li, Nan},
  title = {Ultrasound‐Responsive Dual‐Prodrug Nanoassembly for “Fenestrae‐Restoration Strategy” in Liver Fibrosis Therapy},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {22},
  doi = {10.1002/adma.202518832}
}
Kostenlos starten →